UiPath, Inc.
Every calculator, already run for PATH
Open the full toolkit →You have the numbers on PATH. Get the argument.
A written report on which of these readings actually decide the outcome for UiPath, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
20 analysts covering PATHAnalyst Price Target Disagreement for UiPath, Inc.
Wall Street's bull case implies +5% from the current price; the bear case implies -32%. A 37% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
About UiPath, Inc.
UiPath, Inc. provides an automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. It offers the UiPath platform, an integrated enterprise software platform that enables AI agents, robots, people, and models to work together in coordinated workflows. The company's UiPath platform includes the UiPath Maestro process orchestration and process intelligence; UiPath agent builder; RPA and API automation; UiPath intelligent xtraction and processing; UiPath test cloud for testing and quality assurance; UiPath packaged and prebuilt agentic solutions; and centralized governan…
PATH — frequently asked
Is PATH a buy right now?
Wall Street's consensus rating on UiPath, Inc. is Hold across 20 analysts, with a mean price target of $13.25 (-18% vs. the current $16.23). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is PATH overvalued?
PATH trades at 27.0x trailing earnings, against a DCF fair value of $23 per share. The current price implies 1% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is PATH's next earnings date?
UiPath, Inc. is next scheduled to report earnings around Sep 3, 2026. A full PATH research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for UiPath, Inc.?
Analysts covering UiPath, Inc. (PATH) range from a bear-case target of $10.98 to a bull-case high of $17.00, with a mean consensus target of $13.25 across 16 analysts. The spread of $6.02 (37% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare UiPath, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For UiPath, Inc.
Start with the evergreen guides that matter most for Technology, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full PATH research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on UiPath, Inc., in minutes. 3 free reports included with every account — no credit card required.